Categories: Technology

CompoSecure Schedules Third Quarter 2025 Conference Call for November 10th at 5:00 p.m. ET

 | Source: CompoSecure, Inc.

SOMERSET, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) — CompoSecure, Inc. (NYSE: CMPO), a leader in metal payment cards, security, and authentication solutions, will host a conference call on Monday, November 10, 2025, at 5:00 p.m. Eastern Standard Time (EST) to discuss its financial results for the third quarter ended September 30, 2025. The Company’s results will be reported in a press release prior to the call.

CompoSecure’s leadership will host the conference call, followed by a question-and-answer period.

Date: Monday, November 10, 2025
Time: 5:00 p.m. EST
Dial-in registration link: here
Live webcast registration link: here

We encourage all participants to register at least 15 minutes prior to the 5:00 p.m. EST start time. A live webcast and replay will be available at https://ir.composecure.com/news-events/events. If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About CompoSecure

Founded in 2000, CompoSecure (NYSE: CMPO) is a technology partner to market leaders, fintechs and consumers enabling trust for millions of people around the globe. The company combines elegance, simplicity and security to deliver exceptional experiences and peace of mind in the physical and digital world. CompoSecure’s innovative payment card technology and metal cards with Arculus security and authentication capabilities deliver unique, premium branded experiences, enable people to access and use their financial and digital assets, and ensure trust at the point of a transaction. For more information, please visit www.CompoSecure.com and www.GetArculus.com.

Corporate Contact

Anthony Piniella
Head of Communications, CompoSecure
(917) 208-7724
apiniella@composecure.com

Investor Relations Contact

Sean Mansouri, CFA
Elevate IR
(720) 330-2829
CMPO@elevate-ir.com

GlobeNews Wire

Recent Posts

Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with progression-free survival in patients with indolent non-Hodgkin lymphoma in the watch-and-wait setting

PRESS RELEASE Magnitude of EO2463-induced CD8 T-cell expansion during monotherapy statistically significantly associated with longer…

45 minutes ago

OMEICOS OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA

Feedback from the U.S. Food and Drug Administration (FDA) supports acceleration of OMT-28’s development path…

45 minutes ago

Carbios reaches milestone of 100 batches at its Industrial demonstration plant and expands its licensing offering to the textile market

Validation of the "Fiber-to-Fiber" biorecycling process under conditions representative of industrial operations100th batch1 successfully produced…

45 minutes ago

Canara HSBC Life Insurance Reports Strong Business Momentum, APE Up 19%, VNB rises by 29%

New Business Premium stood at ₹ 1,044 crore registering a growth of 25.2%Individual weighted premium…

46 minutes ago

B&R Technology Merger Corp. Announces Pricing of $325 Million Initial Public Offering

NEW YORK, July 21, 2026 /PRNewswire/ -- B&R Technology Merger Corp. (the "Company") announced the…

46 minutes ago

Winning Ground: The First Online Gambling Report Spanning Every African Nation

Two full years of data show regulated online gambling revenue rising from $4.4 billion in…

2 hours ago